Department Of Emergency Medicine 2
51. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
52. Assessment of Risk Factors for Coronary Artery Restenosis and Patient Survival During the COVID-19 Pandemic
53. Assessment of the Predictive Ability of the Neutrophil-to-Lymphocyte Ratio in Patients with In-Stent Restenosis after COVID-19
54. Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series
55. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
56. The future of diagnostics: cutting-edge advances in healthcare technology
57. Contrast-Induced Kidney Injury Prediction in STEMI Patients Post-Coronary Intervention
58. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
59. Epidemiology of stroke and transient ischemic attacks in the population of the territories adjacent to the former Semipalatinsk Nuclear Test Site, Kazakhstan
60. Social Determinants of Health and Antibiotic Consumption
61. The lessons of COVID-19, SARS, and MERS: Implications for preventive strategies
62. Comparative Evaluation of the Prognostic Accuracy of IL-6 and Angiopoietin-2 for Early Severity Assessment in Acute Pancreatitis: A Systematic Review
63. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
64. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
65. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
66. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
67. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
68. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
69. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
70. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
71. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
72. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
73. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
74. Evaluating the Effectiveness of a First Aid Training Programme for Individuals Without a Background in Medical Education
75. First Aid Training for Non-Medical Professionals: The Need for Comprehensive Assessments [Response to Letter]
76. Impact of COVID-19 on the Risk of Coronary Stent Thrombosis and Restenosis: A Retrospective Angiographic Study
77. Paramedic To Provider Consultation Challenges in the Emergency Department in Kazakhstan: An Online Survey
78. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
79. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1 2 2